OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,069 | -2.1% | 401 | 0.0% | 0.00% | – |
| Q1 2023 | $2,113 | -29.6% | 401 | -40.8% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | -94.9% | 677 | -88.5% | 0.00% | -93.3% |
| Q3 2021 | $59,000 | -49.1% | 5,900 | -28.0% | 0.02% | -42.3% |
| Q2 2021 | $116,000 | -1.7% | 8,200 | +13.9% | 0.03% | -3.7% |
| Q1 2021 | $118,000 | +51.3% | 7,200 | +92.1% | 0.03% | +42.1% |
| Q4 2020 | $78,000 | +239.1% | 3,748 | +24.9% | 0.02% | +216.7% |
| Q3 2020 | $23,000 | -50.0% | 3,000 | -45.2% | 0.01% | -57.1% |
| Q2 2020 | $46,000 | +820.0% | 5,478 | +447.8% | 0.01% | +600.0% |
| Q1 2020 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |